13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000919574-23-001423
Total Value
$39.1M
Positions
17
Other Managers
0
Confidential Omitted
Yes
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAVARA INC | SVRA | 6,896,551 | $10.7M | 27.30% |
| 2 | XERIS BIOPHARMA HOLDINGS INC | XERS | 6,039,028 | $8.0M | 20.52% |
| 3 | SPDR S&P 500 ETF TR | SPY | 15,947 | $6.1M | 15.58% |
| 4 | REZOLUTE INC | RZLT | 1,403,157 | $2.9M | 7.42% |
| 5 | SCYNEXIS INC | SCYX | 1,723,947 | $2.7M | 6.87% |
| 6 | SPDR SER TR | 78468R556 | 17,500 | $2.4M | 6.07% |
| 7 | VECTIVBIO HLDG AG | H9060V101 | 156,222 | $1.3M | 3.44% |
| 8 | ARCELLX INC | ACLX | 36,302 | $1.1M | 2.87% |
| 9 | ALPS ETF TR | 00162Q452 | 29,500 | $1.1M | 2.87% |
| 10 | COMPASS THERAPEUTICS INC | CMPX | 211,159 | $1.1M | 2.71% |
| 11 | CABALETTA BIO INC | CABA | 84,728 | $783,735 | 2.00% |
| 12 | MOLECULAR TEMPLATES INC | 608550109 | 2,052,991 | $673,381 | 1.72% |
| 13 | ALLAKOS INC | 01671P100 | 18,271 | $153,840 | 0.39% |
| 14 | ELEVATION ONCOLOGY INC | 28623U101 | 68,324 | $64,800 | 0.17% |
| 15 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 21,333 | $17,795 | 0.05% |
| 16 | BRIDGETOWN HOLDINGS LTD | G1355U121 | 39,773 | $4,671 | 0.01% |
| 17 | LANVIN GROUP HOLDINGS LIMITE | LANV-WT | 12,000 | $3,776 | 0.01% |